News

In particular, water molecules around the protein’s linker, RRM2, and the RNA strand exhibit significantly more restricted motion compared to RRM1 upon complexation. Further, longer relaxation times ...
RRM2 emerged as the most prognostic gene from this risk score, particularly in the eosinophilic subtype, alongside other clinical variables. By IHC, RRM2 shows high IHC score in eosinophilic compared ...
Five core genes NCAPG, MAD2L1, CDK1, RRM2 and RFC4 were screened from the PPI network. The five genes were highly expressed in sarcoma. Conclusion: The five core common differentially expressed genes ...
Five core genes NCAPG, MAD2L1, CDK1, RRM2 and RFC4 were screened from the PPI network. The five genes were highly expressed in sarcoma. Conclusion: The five core common differentially expressed genes ...
Truncated variants of human MSI1 encompassing the two homologous RNA recognition motifs (RRM1 and RRM2) in tandem (aa 1–200), and the two RRMs in isolation (aa 1–103 and aa 104–200, respectively) were ...
A recently granted patent (Publication Number: US11920134B2) discloses a double-stranded ribonucleic acid molecule designed to inhibit the expression of a ribonucleotide reductase M2 (RRM2) gene. The ...
Background: Ribonucleotide reductase regulatory subunit M2 (RRM2) has been reported to be an oncogene in some malignant tumors, such as lung adenocarcinoma, oral squamous cell carcinoma, glioblastoma, ...
The team also noted that the depletion of CHK1 was sufficient to decrease RRM2 levels and result in DNA damage. Moreover, CHK1 knockdown resulted in the activation of STAT1 and P38 as well as the ...
Moreover, ribonucleotide reductase regulatory subunit M2 (RRM2) was found and verified to promote proliferation of MM cell lines, suggesting RRM2 may serve as a detrimental marker in MM. The ...
The affinity of RRM1 for a single short RNA increased by a factor 80x in the presence of RRM2. The NMR structure revealed the binding consensus sequence and several unusual RNA recognition ...
My research is centered on leveraging advanced mass spectrometry technologies to investigate metabolic reprogramming in cancer development and progression. I have established a robust and independent ...